Atrial fibrillation: From cell to bedside

Journal of Cardiovascular Electrophysiology

Volumn 8, Issue 8, 1997, Pages 927-938

  Zipes, Douglas P ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomics; Remodeling; Tachycardia induced cardiomyopathy

Indexed keywords

EXCITATION CONTRACTION COUPLING; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HUMAN; PRIORITY JOURNAL; REVIEW; PATHOPHYSIOLOGY;

ATRIAL FIBRILLATION; HUMANS;

EID: 0031203341     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1997.tb00855.x     Document Type: Review

References (59)

1. Prystowsky EN, Benson DW Jr, Fuster V, et al: Management of patients with atrial fibrillation: A statement for Healthcare professionals from the Committee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 1996;93:1262-1277.
2. Moe GK: On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140: 183-188.
3. Allessie MA: Reentrant mechanisms underlying atrial fibrillation. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders, Philadelphia, 1995, pp. 562-566.
4. Nattel S, Bourne G, Talajic M: Insights into mechanisms of antiarrhythmic drug action from experimental models of atrial fibrillation. J Cardiovasc Electrophysiol 1997;8:469-480.
5. Wijffels MCEF: Atrial Fibrillation Begets Atrial Fibrillation: An Experimental Study in Chronically Instrumented Goats. Ph.D. Thesis. University of Maastricht, Maastricht, The Netherlands, 1996, pp. 147-179.
6. Sih HJ, Berbari EJ, Zipes DP: Epicardial maps in a canine model of chronic atrial fibrillation after linear ablation lesions. J Am Coll Cardiol 1997;29:253A.
7. Zipes DP, Mihalick MJ, Robbins FT: Effects of selective vagal stellate ganglion stimulation on atrial refractoriness. Cardiovasc Res 1974;8:647-655.
8. Elvan A, Rubart M, Zipes DP: Nitric oxide modulates autonomic effects on spontaneous sinus discharge rate and atrioventricular nodal conduction in open chest anesthetized dogs. Am J Physiol 1997;272:H263-H271.
9. Klein LS, Miles WM, Zipes DP: Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure and refractory period: Contraction-excitation feedback in human atrium. Circulation 1990;82:60-68.
10. Kaseda S, Zipes DP: Contraction-excitation feedback in the atria: A cause of changes in refractoriness. J Am Coll Cardiol 1988;11:1327-1336.
11. Satoh T, Zipes DP: Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:833-842.
12. Haissaguerre M, Marcus FI, Fischer B, et al: Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: Report of three cases. J Cardiovasc Electrophysiol 1994;5:743-751.
13. Jais P, Haissaguerre M, Shah DC, et al: A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-576.
14. Wijffels MCEF, Kirchof CJHJ, Dorland R, et al: Atrial fibrillation begets atrial fibrillation: A study in awake, chronically instrumented goats. Circulation 1995;92: 1954-1968.
15. Morillo CA, Klein GJ, Jones DL, et al: Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
16. Elvan A, Wylie K, Zipes DP: Pacing induced chronic atrial fibrillation impairs sinus node function in dogs. Circulation 1996;94:2953-2960.
17. Elvan A, Huang X, Pressler M, et al: Radiofrequency catheter ablation of the atria eliminates pacing induced sustained atrial fibrillation and reduces connexin43 in dogs. Circulation 1997; (In press).
18. Gray RA, Pertsov AM, Jalife J: Incomplete reentry and epicardial breakthrough patterns during atrial fibrillation in the sheep heart. Circulation 1996;94:2649-2661.
19. Olsson SB, Cotoi S, Varnauskas E: Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. Acta Med Scand 1971;190:381-387.
20. Cotoi S, Gavrilescu S, Pop T, et al: The prognostic value of right atrium monophasic action potential after conversion of atrial fibrillation. Eur J Clin Invest 1972;2:472-474.
21. Attuel P, Childress RW, Cauchemez B, et al: Failure in rate adaptation of the atrial refractory period: Its relation to vulnerability. Int J Cardiol 1982;2:179-197.
22. Yue L, Feng J, Gaspo R, et al: Ionic remodeling underlying tachycardia-induced atrial fibrillation in dogs. (Abstract) Circulation 1996;94(Suppl I):I-592.
23. + channels are reduced in chronic human atrial fibrillation. (Abstract) Circulation 1996;94(Suppl I):I-592.
24. van der Velden HMW, van Zijverden M, van Kemper MJA, et al: Abnormal expression of the gap junction protein connexin40 during chronic atrial fibrillation in the goat. Circulation 1996;94(Suppl I):I-593.
25. Borders M, Ausma J, Thone F, et al: et al: Structural changes of atrial myocardium after chronic atrial fibrillation in the goat. Circulation 1996;94(Suppl I):I-593.
26. Daoud EG, Bogun F, Goyal R, et al: Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94:1600-1606.
27. Tieleman RG, DeLangen CDJ, VanGelder IC, et al: Verapamil reduces tachycardia induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
28. Goette A, Honeycutt C, Langberg JJ: Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.
29. Shachnow N, Spellman S, Rubin I: Persistent supraventricular tachycardia: Case report with review of the literature. Circulation 195410:232-236.
30. Whipple GH, Sheffield LT, Woodman EG, et al: Reversible congestive heart failure due to rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 1962;20:39-40.
31. Spinale FG, Bishop SP: Myocardial remodeling with the development of tachycardia induced heart failure. In Spinale FC: Pathophysiology of Tachycardia Induced Heart Failure. Futura Publishing Co., Inc., Armonk, NY, 1996, pp. 61-87.
32. Spinale FG: Myocyte contractile processes with the development of tachycardia induced heart failure. In Spinale FG: Pathophysiology of Tachycardia Induced Heart Failure. Futura Publishing Co., Inc., Armonk, NY, 1996, pp. 89-123.
33. Kajstura J, Zhang X, Liu Y, et al: The cellular basis of pacing induced dilated cardiomyopathy: Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995;92:2306-2317.
34. Eble DM, Spinale FG: Effects of chronic supraventricular tachycardia on contractile and non-contractile mRNA expression: Relation to changes in myocyte structure and function. Am J Physiol 1995;268:H2426-H2439.
35. Williams RE, Cass DA, Kawagoe Y, et al: Endomyocardial gene expression during the development of pacing tachycardia induced heart failure in the dog. Circ Res 1994;75:615-623.
36. Mukherjee R, Hewett KW, Spinale FG: Myocyte electrophysiological properties following the development of supraventricular tachycardia induced cardiomyopathy. J Mol Cell Cardiol 1995;27:1333-1348.
37. Kaab S, Nuss HB, Chiamvimonvat N, et al: Ionicmechanism of action potential prolongation in ventricular myocytes from dogs with pacing induced heart failure. Circ Res 1996;78:262-273.
38. Satoh T, Zipes DP: Rapid rates during bradycardia pacing prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation 1996;94:217-227.
39. Rubart M, Zipes DP: Transient tachycardia superimposed on bradycardia prolongs repolarization in isolated canine ventricular myocytes. (Abstract) J Am Coll Cardiol 1997;29(Suppl A):62A.
40. Roden DM, Woosely RL, Primm RK: Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. Am Heart J 1986;111:1088-1093.
41. Choy AMJ, Darbar D, Dell'Orto S, et al: Increased sensitivity to QT prolonging drugs immediately after conversion to sinus rhythm. (Abstract) Circulation 1996;94:1202.
42. Brandt RR, Shen W-K: Bradycardia-induced polymorphic ventricular tachycardia after atrioventricular junction ablation for sinus tachycardia-induced cardiomyopathy. J Cardiovasc Electrophysiol 1995;6:630-633.
43. Levine JH, Guarnieri T, White RI, et al: Alterations of repolarization during valvuloplasty: Evidence for contraction excitation feedback in humans. Circulation 1988;77:70-77.
44. Olgin JE, Kalman JM, Chin M, et al: Role of autonomic tone and atrial size on electrical remodeling in a canine model of atrial fibrillation. (Abstract) Circulation 1996;94(Suppl I):I-352.
45. Ayers GM, Rho TH, Ben-David J, et al: Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:713-721.
46. Miyazaki T, Pride HP, Zipes DP: Modulation of cardiac autonomic neurotransmission by epicardial superfusion: Effects of hexamethonium and tetrodotoxin. Circ Res 1989;65:1212-1219.
47. Miyazaki T, Pride HP, Zipes DP: Prostaglandins in the pericardial fluid modulate neural regulation of cardiac electrophysiologic properties. Circ Res 1990;66:163-175.
48. +, low pH and adenosine: Possible relevance to ischemia-induced denervation. Circ Res 1990;66:289-301.
49. Miyazaki T, Zipes DP: Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs. Circulation 1990;82:1008-1019.
50. Fei L, Arnett C, Zipes DP: L-Arginine reduces the increased incidence of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary artery occlusion. J Am Coll Cardiol 1997;29:268A.
51. Williamson BD, Man KC, Daoud E, et al: Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994;331:910-917.
52. Hillsley RE, Wharton JM: Implantable atrial defibrillators. J Cardiovasc Electrophysiol 1995;6:634-648.
53. Saksena S, Prakash A, Hill M, et al: Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996;28:687-694.
54. Cox JL, Jaquiss RD, Schuessler RB, et al: Modification of the maze procedure for atrial flutter and fibrillation. II: Surgical technique of the maze II procedure. J Thorac Cardiovasc Surg 1995;110:485-495.
55. Elvan A, Pride HP, Eble JN, et al: Radiofrequency catheter ablation of the atria reduces the inducibility and duration of atrial fibrillation in dogs. Circulation 1995;91:2235-2244.
56. Swartz JF, Pellersels G, Silvers J, et al: et al: Catheter based curative approach to atrial fibrillation in humans. (Abstract) Circulation 1994;90(Suppl I):I-335.
57. Haissaguerre M: Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:1132-1144.
58. Kalman J, Olgin J, Karch M, et al: Effect of right atrial linear lesions on atrial defibrillation threshold: Implications for "hybrid therapy." PACE 1996;19:625.
59. Chiou CW, Eble JN, Zipes DP: Efferent vagal innervation of the canine atria, sinus and atrioventricular nodes: The third fat pad. Circulation 1997;95:2573-2584.